VAIA
AMED

Virtus Alternative Investment Advisers’s Amedisys AMED Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24
Closed -$7K – 13
2020
Q4 		$7K Sell
24
-23
-49% -$5.9K 0.1% 105
2020
Q3 		$11K Sell
47
-17
-27% -$3.87K 0.2% 91
2020
Q2 		$13K Sell
64
-61
-49% -$11.4K 0.2% 183
2020
Q1 		$23K Buy
125
+67
+116% +$11.9K 0.32% 27
2019
Q4 		$10K Buy
+58
New +$8.63K 0.15% 22

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Virtus Alternative Investment Advisers's AMED Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Amedisys (AMED) in Q1 2021, closing a stake of 24 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in AMED in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 24 Amedisys shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in Amedisys in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Amedisys position peaked at $23K in Q1 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.